115 related articles for article (PubMed ID: 10372724)
21. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations.
Hove K; Horst RL; Littledike ET; Beitz DC
Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544
[TBL] [Abstract][Full Text] [Related]
22. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
[TBL] [Abstract][Full Text] [Related]
23. Episodic secretion of parathyroid hormone in postmenopausal women: assessment by deconvolution analysis and approximate entropy.
Samuels MH; Veldhuis JD; Kramer P; Urban RJ; Bauer R; Mundy GR
J Bone Miner Res; 1997 Apr; 12(4):616-23. PubMed ID: 9101373
[TBL] [Abstract][Full Text] [Related]
24. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
25. Effect of calcium and 1,25 dihydroxyvitamin D on the level of parathyroid hormone in patients with secondary hyperparathyroidism due to chronic renal insufficiency.
Vucković S; Paunković N
Med Pregl; 1993; 46 Suppl 1():40-2. PubMed ID: 8569602
[TBL] [Abstract][Full Text] [Related]
26. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women.
Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
Eur J Clin Invest; 2001 Sep; 31(9):764-72. PubMed ID: 11589718
[TBL] [Abstract][Full Text] [Related]
27. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
Liu XX; Zhu XY; Mei GH
Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
[TBL] [Abstract][Full Text] [Related]
29. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
Kates DM; Sherrard DJ; Andress DL
Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
[TBL] [Abstract][Full Text] [Related]
30. Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men.
Burnett-Bowie SM; Henao MP; Dere ME; Lee H; Leder BZ
J Bone Miner Res; 2009 Oct; 24(10):1681-5. PubMed ID: 19419295
[TBL] [Abstract][Full Text] [Related]
31. The aged rat model of ovarian hormone deficiency bone loss.
Kalu DN; Liu CC; Hardin RR; Hollis BW
Endocrinology; 1989 Jan; 124(1):7-16. PubMed ID: 2909382
[TBL] [Abstract][Full Text] [Related]
32. Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans.
Brent GA; LeBoff MS; Seely EW; Conlin PR; Brown EM
J Clin Endocrinol Metab; 1988 Nov; 67(5):944-50. PubMed ID: 3141451
[TBL] [Abstract][Full Text] [Related]
33. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
34. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone increases circulating levels of fibronectin in vivo: modulating effect of ovariectomy.
Sun BH; Mitnick M; Eielson C; Yao GQ; Paliwal I; Insogna K
Endocrinology; 1997 Sep; 138(9):3918-24. PubMed ID: 9275082
[TBL] [Abstract][Full Text] [Related]
36. Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat.
Ismail F; Epstein S; Fallon MD; Thomas SB; Reinhardt TA
Endocrinology; 1988 Feb; 122(2):624-30. PubMed ID: 3257440
[TBL] [Abstract][Full Text] [Related]
37. Effects of estrogen on response to edetic acid infusion in postmenopausal osteoporotic women.
Cosman F; Nieves J; Horton J; Shen V; Lindsay R
J Clin Endocrinol Metab; 1994 Apr; 78(4):939-43. PubMed ID: 8157725
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
39. Calcium-regulating hormones across the menstrual cycle.
Muse KN; Manolagas SC; Deftos LJ; Alexander N; Yen SS
J Clin Endocrinol Metab; 1986 Jun; 62(6):1313-6. PubMed ID: 3084541
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats.
Toromanoff A; Ammann P; Mosekilde L; Thomsen JS; Riond JL
Endocrinology; 1997 Jun; 138(6):2449-57. PubMed ID: 9165035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
